BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CURO
3176
DELISTED
CURO Group Holdings Corp.
CURO
| $23.1M | ﹤0.01% |
1,332,633
-5,850
| -0.4% | -$96.3K |
|
3177
CALL
VanEck Semiconductor ETF
SMH
$72.5B
| $23.1M | ﹤0.01% |
180,000
-1,956,800
| -92% | -$258M |
|
|
IAS
3178
DELISTED
Integral Ad Science
IAS
| $23M | ﹤0.01% |
1,116,862
+866,862
| +347% | +$17.1M |
|
3179
BCE
BCE
$21.6B
| $23M | ﹤0.01% |
459,672
+24,783
| +6% | +$1.25M |
|
3180
Acacia Research
ACTG
$455M
| $23M | ﹤0.01% |
3,386,944
-9,431
| -0.3% | -$57.8K |
|
3181
Cogent Biosciences
COGT
$6.76B
| $23M | ﹤0.01% |
2,732,235
+54,847
| +2% | +$420K |
|
|
STXB
3182
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $22.9M | ﹤0.01% |
947,352
-10,906
| -1% | -$251K |
|
3183
Blue Bird Corp
BLBD
$2.04B
| $22.8M | ﹤0.01% |
1,093,813
-12,240
| -1% | -$272K |
|
|
FFAI
3184
Faraday Future Intelligent Electric
FFAI
$12M
| $22.7M | ﹤0.01% |
+2
| New | +$32.9M |
|
3185
Rocky Brands
RCKY
$353M
| $22.7M | ﹤0.01% |
477,737
-18,717
| -4% | -$931K |
|
|
KZR
3186
DELISTED
Kezar Life Sciences
KZR
| $22.7M | ﹤0.01% |
263,182
+3,202
| +1% | +$212K |
|
3187
CNB Financial Corp
CCNE
$1.04B
| $22.7M | ﹤0.01% |
933,793
-40,182
| -4% | -$965K |
|
3188
Prelude Therapeutics
PRLD
$457M
| $22.7M | ﹤0.01% |
725,962
+23,120
| +3% | +$749K |
|
3189
Zymeworks
ZYME
$1.77B
| $22.6M | ﹤0.01% |
778,299
-193,434
| -20% | -$6.43M |
|
3190
Korro Bio
KRRO
$197M
| $22.5M | ﹤0.01% |
63,837
+2,422
| +4% | +$953K |
|
3191
Kodak
KODK
$992M
| $22.5M | ﹤0.01% |
3,308,191
+46,052
| +1% | +$336K |
|
|
IMGO
3192
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $22.5M | ﹤0.01% |
+1,124,493
| New | +$24.1M |
|
3193
NWPX Infrastructure Inc
NWPX
$1.1B
| $22.5M | ﹤0.01% |
949,714
+45,882
| +5% | +$1.21M |
|
|
OLK
3194
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $22.5M | ﹤0.01% |
928,016
-128,300
| -12% | -$4.03M |
|
3195
iShares Core MSCI Europe ETF
IEUR
$9.15B
| $22.5M | ﹤0.01% |
401,175
+55,610
| +16% | +$3.24M |
|
3196
Puma Biotechnology
PBYI
$450M
| $22.5M | ﹤0.01% |
3,207,661
+141,897
| +5% | +$1.06M |
|
|
EGIO
3197
DELISTED
Edgio, Inc. Common Stock
EGIO
| $22.5M | ﹤0.01% |
236,141
-8,057
| -3% | -$849K |
|
3198
AXT Inc
AXTI
$5.07B
| $22.4M | ﹤0.01% |
2,688,757
-104,894
| -4% | -$977K |
|
3199
Lexicon Pharmaceuticals
LXRX
$1.04B
| $22.4M | ﹤0.01% |
4,650,670
+3,811
| +0.1% | +$15.6K |
|
|
KVSA
3200
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $22.3M | ﹤0.01% |
2,259,644
| – | – |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.